256 related articles for article (PubMed ID: 33536399)
1. Multi-Institutional Prospective Cohort Study of Patients With Pulmonary Hypertension Associated With Respiratory Diseases.
Tanabe N; Kumamaru H; Tamura Y; Taniguchi H; Emoto N; Yamada Y; Nishiyama O; Tsujino I; Kuraishi H; Nishimura Y; Kimura H; Inoue Y; Morio Y; Nakatsumi Y; Satoh T; Hanaoka M; Kusaka K; Sumitani M; Handa T; Sakao S; Kimura T; Kondoh Y; Nakayama K; Tanaka K; Ohira H; Nishimura M; Miyata H; Tatsumi K;
Circ J; 2021 Mar; 85(4):333-342. PubMed ID: 33536399
[TBL] [Abstract][Full Text] [Related]
2. Multi-institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases.
Tanabe N; Taniguchi H; Tsujino I; Sakamaki F; Emoto N; Kimura H; Takamura K; Hanaoka M; Nishimura M; Tatsumi K;
Respirology; 2015 Jul; 20(5):805-12. PubMed ID: 25828844
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry.
Tanabe N; Kumamaru H; Tamura Y; Kondoh Y; Nakayama K; Kinukawa N; Kimura T; Nishiyama O; Tsujino I; Shigeta A; Morio Y; Inoue Y; Kuraishi H; Hirata KI; Tanaka K; Kuwana M; Nagaoka T; Handa T; Sugimura K; Sakamaki F; Naito A; Taniguchi Y; Matsubara H; Hanaoka M; Inami T; Hayama N; Nishimura Y; Kimura H; Miyata H; Tatsumi K;
JACC Asia; 2024 May; 4(5):403-417. PubMed ID: 38765657
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
[TBL] [Abstract][Full Text] [Related]
5. Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database.
Kitahara K; Omura J; Wada S; Kim SW
Pulm Ther; 2024 Mar; 10(1):21-49. PubMed ID: 37950789
[TBL] [Abstract][Full Text] [Related]
6. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
[TBL] [Abstract][Full Text] [Related]
7. [Disproportionate pulmonary arterial hypertension and lung respiratory diseases: distinctive clinical, hemodynamic and prognosis of patients versus primary pulmonary arterial hypertension].
Hugues T; Lemoigne F; Macone F; Cerboni P; Gibelin P
Ann Cardiol Angeiol (Paris); 2012 Feb; 61(1):1-7. PubMed ID: 21679923
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
9. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary arterial hypertension.
Montani D; Günther S; Dorfmüller P; Perros F; Girerd B; Garcia G; Jaïs X; Savale L; Artaud-Macari E; Price LC; Humbert M; Simonneau G; Sitbon O
Orphanet J Rare Dis; 2013 Jul; 8():97. PubMed ID: 23829793
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis.
Farmakis IT; Vazakidis P; Doundoulakis I; Arvanitaki A; Zafeiropoulos S; Boutou A; Karvounis H; Giannakoulas G
Pulm Pharmacol Ther; 2021 Jun; 68():102036. PubMed ID: 33979684
[TBL] [Abstract][Full Text] [Related]
13. Current trends in the management of pulmonary hypertension associated with respiratory disease in institutions approved by the Japanese Respiratory Society.
Tanabe N; Taniguchi H; Tsujino I; Sakamaki F; Emoto N; Kimura H; Miyaji K; Takamura K; Hayashi S; Hanaoka M; Tatsumi K;
Respir Investig; 2014 May; 52(3):167-72. PubMed ID: 24853016
[TBL] [Abstract][Full Text] [Related]
14. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
[TBL] [Abstract][Full Text] [Related]
15. Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype.
Steger M; Canuet M; Enache I; Goetsch T; Labani A; Meyer L; Martin G; Kessler R; Montani D; Riou M
Respir Med; 2024; 225():107585. PubMed ID: 38479707
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension and right heart dysfunction in chronic lung disease.
Zangiabadi A; De Pasquale CG; Sajkov D
Biomed Res Int; 2014; 2014():739674. PubMed ID: 25165714
[TBL] [Abstract][Full Text] [Related]
17. Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension.
Chung WJ; Park YB; Jeon CH; Jung JW; Ko KP; Choi SJ; Seo HS; Lee JS; Jung HO;
J Korean Med Sci; 2015 Oct; 30(10):1429-38. PubMed ID: 26425039
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry.
Kaemmerer H; Gorenflo M; Huscher D; Pittrow D; Apitz C; Baumgartner H; Berger F; Bruch L; Brunnemer E; Budts W; Claussen M; Coghlan G; Dähnert I; D'Alto M; Delcroix M; Distler O; Dittrich S; Dumitrescu D; Ewert R; Faehling M; Germund I; Ghofrani HA; Grohé C; Grossekreymborg K; Halank M; Hansmann G; Harzheim D; Nemes A; Havasi K; Held M; Hoeper MM; Hofbeck M; Hohenfrost-Schmidt W; Jurevičienė E; Gumbienè L; Kabitz HJ; Klose H; Köhler T; Konstantinides S; Köestenberger M; Kozlik-Feldmann R; Kramer HH; Kropf-Sanchen C; Lammers A; Lange T; Meyn P; Miera O; Milger-Kneidinger K; Neidenbach R; Neurohr C; Opitz C; Perings C; Remppis BA; Riemekasten G; Scelsi L; Scholtz W; Simkova I; Skowasch D; Skride A; Stähler G; Stiller B; Tsangaris I; Vizza CD; Vonk Noordegraaf A; Wilkens H; Wirtz H; Diller GP; Grünig E; Rosenkranz S
J Clin Med; 2020 May; 9(5):. PubMed ID: 32414075
[TBL] [Abstract][Full Text] [Related]
19. Right ventricular dilatation, right ventricular wall thickening, and Doppler evidence of pulmonary hypertension in patients with a pure restrictive ventilatory impairment.
Shivkumar K; Ravi K; Henry JW; Eichenhorn M; Stein PD
Chest; 1994 Dec; 106(6):1649-53. PubMed ID: 7988179
[TBL] [Abstract][Full Text] [Related]
20. Out of proportion pulmonary hypertension in obstructive lung diseases.
Chatterjee K; Tarawneh AR; Alam S
Curr Opin Pulm Med; 2018 Mar; 24(2):161-172. PubMed ID: 29256906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
